Option Care Health Inc (OPCH)
NASDAQ:OPCH
Want to see OPCH full AI Analyst Report?
OPCH Stock Chart & Stats
$28.82
-$0.14(-0.58%)
At close: 4:00 PM EST
$28.82
-$0.14(-0.58%)
Day’s Range― - ―
52-Week Range$18.01 - $36.80
Previous CloseN/A
Volume256.90K
Average Volume (3M)3.52M
Market Cap
$3.34B
Enterprise Value$4.50B
Total Cash (Recent Filing)$177.32M
Total Debt (Recent Filing)$1.27B
Price to Earnings (P/E)17.0
Beta0.43
Next Earnings
Aug 05, 2026EPS Estimate
0.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.29
Shares Outstanding157,027,510
10 Day Avg. Volume3,214,101
30 Day Avg. Volume3,518,373
Financial Highlights & Ratios
PEG Ratio6.12
Price to Book (P/B)3.89
Price to Sales (P/S)0.91
P/FCF Ratio23.78
Enterprise Value/Market Cap1.35
Enterprise Value/Revenue0.79
Enterprise Value/Gross Profit4.41
Enterprise Value/Ebitda10.94
Forecast
1Y Price Target
$30.00Price Target Upside4.09% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)1.83
Revenue Forecast (FY)$5.73B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthZero total debt and a sizable equity base materially reduce refinancing and solvency risk, providing durable financial flexibility. That optionality supports working-capital management, the revolver expansion, tuck-in M&A, and measured buybacks while the company rebuilds chronic census over several quarters.
Re-accelerated Revenue MomentumTop-line re-acceleration to 31.3% TTM shows strong underlying demand and execution, improving scale economics and cash generation potential. Sustained revenue growth funds reinvestment in commercial coverage and clinic expansion, important for multi-quarter recovery after therapy-specific headwinds.
Clinic/acute Execution & Patient Experience14% clinic visit growth and very strong patient satisfaction/NPS indicate durable clinical quality and referral strength. Higher clinic utilization drives mix toward higher-margin acute infusion services and supports sustainable margin recovery as the industry shifts to home and alternate-site care over the next several quarters.
Bears Say
CID/Stelara Gross-profit HeadwindA $55M gross-profit hit from the CID/Stelara reset is a material structural drag on revenue and margins. Management notes patient reverification and census losses; rebuilding chronic volumes and payer coverage takes multiple quarters, constraining revenue recovery and margin normalization in the medium term.
Margin CompressionMeaningful margin erosion versus prior years reduces earnings resiliency and leaves less room to absorb reimbursement pressure or invest commercially. With SG&A rising and therapy mix shifts, sustained margin pressure could limit free cash flow durability and slow multi-quarter margin recovery.
Variable Cash ConversionOperating cash flow conversion is inconsistent, with a drop to ~0.31 OCF-to-net income and a Q1 cash use. Volatile cash conversion raises execution risk for capital allocation (buybacks, M&A, investments) and increases reliance on revolver capacity during quarters of slower specialty or chronic therapy collections.
Option Care Health News
OPCH FAQ
What was Option Care Health Inc’s price range in the past 12 months?
Option Care Health Inc lowest stock price was $18.01 and its highest was $36.80 in the past 12 months.
What is Option Care Health Inc’s market cap?
Option Care Health Inc’s market cap is $3.34B.
When is Option Care Health Inc’s upcoming earnings report date?
Option Care Health Inc’s upcoming earnings report date is Aug 05, 2026 which is in 42 days.
How were Option Care Health Inc’s earnings last quarter?
Option Care Health Inc released its earnings results on Apr 30, 2026. The company reported $0.4 earnings per share for the quarter, beating the consensus estimate of $0.371 by $0.029.
Is Option Care Health Inc overvalued?
According to Wall Street analysts Option Care Health Inc’s price is currently Undervalued.
Does Option Care Health Inc pay dividends?
Option Care Health Inc does not currently pay dividends.
What is Option Care Health Inc’s EPS estimate?
Option Care Health Inc’s EPS estimate is 0.43.
How many shares outstanding does Option Care Health Inc have?
Option Care Health Inc has 157,027,510 shares outstanding.
What happened to Option Care Health Inc’s price movement after its last earnings report?
Option Care Health Inc reported an EPS of $0.4 in its last earnings report, beating expectations of $0.371. Following the earnings report the stock price went down -24.339%.
Which hedge fund is a major shareholder of Option Care Health Inc?
Currently, no hedge funds are holding shares in OPCH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Option Care Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$30.00 (4.09% Upside)
$30.00 (4.09% Upside)
Blogger Sentiment
Bullish
OPCH Sentiment 67%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 50.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 5.4%
Last 30 Days ▼ 5.4%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.44%
12-Months-Change
Fundamentals
Return on Equity
15.28%
Trailing 12-Months
Asset Growth
2.16%
Trailing 12-Months
Company Description
Option Care Health Inc
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
OPCH Company Deck
OPCH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call described a mixed quarter: strong execution in acute therapies, clinic utilization growth, patient satisfaction and preserved profitability guidance were offset by a material chronic portfolio reset (notably Stelara/CID), a larger-than-anticipated $55 million gross profit headwind, patient census declines and related revenue shortfall. Management communicated targeted commercial and operational actions, expanded liquidity, and confidence that the CID reset is largely a one-time event, but rebuilding chronic census and recovering revenue momentum will take time.View all OPCH earnings summariesOPCH Stock 12 Month Forecast
Average Price Target
$30.00
▲(4.09% Upside)
Technical Analysis
Addus Homecare
―
Chemed
―
National Healthcare
―
Surgery Partners
―
Aveanna Healthcare Holdings
―
Ownership Overview
1.27% Insiders
35.99% Mutual Funds
31.65% Other Institutional Investors
3.00% Public Companies and
Individual Investors